JP2014502143A5 - - Google Patents

Download PDF

Info

Publication number
JP2014502143A5
JP2014502143A5 JP2013532945A JP2013532945A JP2014502143A5 JP 2014502143 A5 JP2014502143 A5 JP 2014502143A5 JP 2013532945 A JP2013532945 A JP 2013532945A JP 2013532945 A JP2013532945 A JP 2013532945A JP 2014502143 A5 JP2014502143 A5 JP 2014502143A5
Authority
JP
Japan
Prior art keywords
rsv
polypeptide
seq
vlp
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013532945A
Other languages
English (en)
Japanese (ja)
Other versions
JP6023061B2 (ja
JP2014502143A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/055113 external-priority patent/WO2012048115A2/en
Publication of JP2014502143A publication Critical patent/JP2014502143A/ja
Publication of JP2014502143A5 publication Critical patent/JP2014502143A5/ja
Application granted granted Critical
Publication of JP6023061B2 publication Critical patent/JP6023061B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013532945A 2010-10-06 2011-10-06 ポリペプチド、ならびに呼吸器多核体ウイルス感染症の治療および制限における該ポリペプチドの使用 Expired - Fee Related JP6023061B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39059110P 2010-10-06 2010-10-06
US61/390,591 2010-10-06
PCT/US2011/055113 WO2012048115A2 (en) 2010-10-06 2011-10-06 Polypeptides and their use in treating and limiting respiratory syncytial virus infection

Publications (3)

Publication Number Publication Date
JP2014502143A JP2014502143A (ja) 2014-01-30
JP2014502143A5 true JP2014502143A5 (cg-RX-API-DMAC7.html) 2014-10-30
JP6023061B2 JP6023061B2 (ja) 2016-11-09

Family

ID=44993163

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013532945A Expired - Fee Related JP6023061B2 (ja) 2010-10-06 2011-10-06 ポリペプチド、ならびに呼吸器多核体ウイルス感染症の治療および制限における該ポリペプチドの使用

Country Status (7)

Country Link
US (1) US9718862B2 (cg-RX-API-DMAC7.html)
EP (1) EP2625194B1 (cg-RX-API-DMAC7.html)
JP (1) JP6023061B2 (cg-RX-API-DMAC7.html)
CN (1) CN103282378B (cg-RX-API-DMAC7.html)
AU (1) AU2011311946B8 (cg-RX-API-DMAC7.html)
CA (1) CA2813752A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012048115A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103282378B (zh) 2010-10-06 2015-03-11 华盛顿大学商业中心 多肽及其在治疗和限制呼吸道合胞病毒感染中的用途
US9701720B2 (en) 2012-04-05 2017-07-11 University Of Washington Through Its Center For Commercialization Epitope-scaffold immunogens against respiratory syncytial virus (RSV)
EP4582098A3 (en) * 2015-11-09 2025-12-24 CureVac SE Optimized nucleic acid molecules
RU2019142012A (ru) 2017-06-14 2021-07-14 Вирометикс Аг Циклические пептиды для защиты от респираторно-синцитиального вируса
CN113260377B (zh) 2018-12-20 2025-08-22 维罗米蒂克斯股份公司 脂肽构建块和合成病毒样颗粒
CN110853704B (zh) * 2019-11-11 2020-11-06 腾讯科技(深圳)有限公司 蛋白质数据获取方法、装置、计算机设备及存储介质

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334394A (en) 1990-06-22 1994-08-02 The Regents Of The University Of California Human immunodeficiency virus decoy
US5770380A (en) 1996-09-13 1998-06-23 University Of Pittsburgh Synthetic antibody mimics--multiple peptide loops attached to a molecular scaffold
US7138103B2 (en) * 1998-06-22 2006-11-21 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
RU2245163C2 (ru) 1998-11-30 2005-01-27 Сайтос Байотекнолэджи АГ Композиция (варианты), способ получения не природной упорядоченной и содержащей повторы антигенной матрицы, способ терапевтического лечения и способ иммунизации
US6955717B2 (en) 2001-05-01 2005-10-18 Medimmune Inc. Crystals and structure of Synagis Fab
US7097841B2 (en) 2002-05-10 2006-08-29 New Century Pharmaceuticals, Inc. Ferritin fusion proteins for use in vaccines and other applications
JP2008513540A (ja) 2004-09-21 2008-05-01 メディミューン,インコーポレーテッド 呼吸器合胞体ウイルスに対する抗体及び該ウイルス用のワクチンを製造する方法
WO2008025015A2 (en) 2006-08-25 2008-02-28 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Epitope-protein scaffolds and their use
HUE029258T2 (en) * 2007-12-24 2017-02-28 Id Biomedical Corp Quebec Recombinant rsv antigens
WO2009100376A2 (en) 2008-02-07 2009-08-13 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Antigenic cloaking and its use
US8580270B2 (en) 2008-09-30 2013-11-12 University Of Massachusetts Respiratory synctial virus (RSV) sequences for protein expression and vaccines
US20120315270A1 (en) 2009-10-21 2012-12-13 The United States Of America, As Represented By The Rsv immunogens, antibodies and compositions thereof
CN103282378B (zh) 2010-10-06 2015-03-11 华盛顿大学商业中心 多肽及其在治疗和限制呼吸道合胞病毒感染中的用途
US9701720B2 (en) 2012-04-05 2017-07-11 University Of Washington Through Its Center For Commercialization Epitope-scaffold immunogens against respiratory syncytial virus (RSV)

Similar Documents

Publication Publication Date Title
US12239699B2 (en) Immunogen for broad-spectrum influenza vaccine and application thereof
JP6949027B2 (ja) ジカウイルスワクチン
CN113666990B (zh) 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用
JP2014502143A5 (cg-RX-API-DMAC7.html)
JP2010166921A5 (cg-RX-API-DMAC7.html)
Jiang et al. Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy
CN104293741A (zh) 一种呼吸道合胞病毒病毒样颗粒疫苗及其制备方法和应用
JP2019506175A5 (cg-RX-API-DMAC7.html)
WO2023023940A1 (zh) 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用
CN118994328A (zh) 呼吸道合胞病毒疫苗及其制备方法和应用
CN102127554B (zh) 一种日本脑炎颗粒疫苗及其制备方法和应用
JP2012517239A5 (cg-RX-API-DMAC7.html)
CN103316357B (zh) 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法
RU2018103757A (ru) Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита
Madhukalya et al. Nipah virus: pathogenesis, genome, diagnosis, and treatment
CN103298936A (zh) 具有新型流感病毒来源的血凝素蛋白基因的重组痘苗病毒
CN111514287A (zh) 甲型流感通用型dna疫苗及其制备方法和应用
CN118421571A (zh) 表达尼帕病毒囊膜糖蛋白的嵌合型vsv重组病毒及其应用
CN117398456A (zh) 一种特异性标记异源蛋白的肿瘤新抗原疫苗体系及其应用
CN102813920A (zh) 一种疫苗佐剂
Albalaty et al. SARS-CoV-2 vaccines from A to Z: A review of the current challenges
CA3221953A1 (en) Broadly reactive viral antigens as immunogens, compositions and methods of use thereof
CN105218679A (zh) 人偏肺病毒多表位抗原及其应用
WO2022000845A1 (zh) 一种预防SARS-CoV-2的重组蛋白疫苗及其制备方法
Tsujimura et al. Allergy vaccines using a mycobacterium-secreted antigen, Ag85B, and an IL-4 antagonist